Influence of Delivery Devices on Efficacy of Inhaled Fluticasone Propionate: A Comparative Study in Stable Asthma Patients

Background: Inhaled corticosteroids are the preferred treatment for long-term control of all grades of persistent asthma. These are administered by various delivery devices with very little information whether these devices can affect the efficacy of inhaled corticosteroids. Fluticasone propiona...

Full description

Bibliographic Details
Main Authors: Bhanu Prakash Kolasani, Venu Madhavi Lanke, Sudheer Diyya
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2013-09-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/3348/22-%206705_E(%20_%20)_PF1(%20_%20)_F(H)_PF1(P)_PF2(PP).pdf
id doaj-6e4b5be8c9884b5c946450d873de10ff
record_format Article
spelling doaj-6e4b5be8c9884b5c946450d873de10ff2020-11-25T03:18:59ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2013-09-01791908191210.7860/JCDR/2013/6705.3348Influence of Delivery Devices on Efficacy of Inhaled Fluticasone Propionate: A Comparative Study in Stable Asthma PatientsBhanu Prakash Kolasani0Venu Madhavi Lanke1Sudheer Diyya2Assistant Professor, Department of Pharmacology, Ragiv Gandhi Institute of Medical Sciences, Principal, RIMS, Kadapa, Andhra Pradesh, India.Assistant Professor, Department of Pharmacology, Ragiv Gandhi Institute of Medical Sciences, Putlampalli, Kadapa, Andhra Pradesh-516002, India.Assistant Professor, Department of Pulmonology, Ragiv Gandhi Institute of Medical Sciences, Putlampalli, Kadapa, Andhra Pradesh-516002, India.Background: Inhaled corticosteroids are the preferred treatment for long-term control of all grades of persistent asthma. These are administered by various delivery devices with very little information whether these devices can affect the efficacy of inhaled corticosteroids. Fluticasone propionate is a relatively new inhalational corticosteroid compared to older ones like beclomethasone and budesonide. Aims & Objective: To assess the relative efficacy of fluticasone propionate administered from different delivery devices to adult patients of chronic stable bronchial asthma as measured by pulmonary function test parameters. Material and Methods: This prospective study was undertaken to assess the relative efficacy of fluticasone propionate administered from different delivery devices to adult patients of chronic stable bronchial asthma as measured by pulmonary function test parameters. Fourty eight subjects were administered, fluticasone propionate (250 μg) by dry powder inhaler, metered dose inhaler, metered dose inhaler with spacer and fluticasone (1mg) via nebulizer consecutively each week for four weeks under direct supervision. Pulmonary function test was done before and one hour after administration of the drug on each visit. Results: After excluding nine patients who were lost to follow up, data was analysed for the remaining thirty nine patients and no significant difference in peak expiratory flow rate (p=0.77), forced expiratory volume in one second (p=0.95), forced vital capacity (p=0.24) and forced expiratory volume in one second and forced vital capacity ratio (p=0.22) was seen after giving fluticasone by different devices. Conclusion: Fluticasone propionate delivered by different devices like dry powder inhaler, metered dose inhaler, metered dose inhaler with spacer and nebulizer have similar effect on lung function in patients of chronic stable bronchial asthma and may be used interchangeably.https://jcdr.net/articles/PDF/3348/22-%206705_E(%20_%20)_PF1(%20_%20)_F(H)_PF1(P)_PF2(PP).pdfpeak expiratory flow rateforced vital capacitymetered dose inhalerfluticasone propionate
collection DOAJ
language English
format Article
sources DOAJ
author Bhanu Prakash Kolasani
Venu Madhavi Lanke
Sudheer Diyya
spellingShingle Bhanu Prakash Kolasani
Venu Madhavi Lanke
Sudheer Diyya
Influence of Delivery Devices on Efficacy of Inhaled Fluticasone Propionate: A Comparative Study in Stable Asthma Patients
Journal of Clinical and Diagnostic Research
peak expiratory flow rate
forced vital capacity
metered dose inhaler
fluticasone propionate
author_facet Bhanu Prakash Kolasani
Venu Madhavi Lanke
Sudheer Diyya
author_sort Bhanu Prakash Kolasani
title Influence of Delivery Devices on Efficacy of Inhaled Fluticasone Propionate: A Comparative Study in Stable Asthma Patients
title_short Influence of Delivery Devices on Efficacy of Inhaled Fluticasone Propionate: A Comparative Study in Stable Asthma Patients
title_full Influence of Delivery Devices on Efficacy of Inhaled Fluticasone Propionate: A Comparative Study in Stable Asthma Patients
title_fullStr Influence of Delivery Devices on Efficacy of Inhaled Fluticasone Propionate: A Comparative Study in Stable Asthma Patients
title_full_unstemmed Influence of Delivery Devices on Efficacy of Inhaled Fluticasone Propionate: A Comparative Study in Stable Asthma Patients
title_sort influence of delivery devices on efficacy of inhaled fluticasone propionate: a comparative study in stable asthma patients
publisher JCDR Research and Publications Private Limited
series Journal of Clinical and Diagnostic Research
issn 2249-782X
0973-709X
publishDate 2013-09-01
description Background: Inhaled corticosteroids are the preferred treatment for long-term control of all grades of persistent asthma. These are administered by various delivery devices with very little information whether these devices can affect the efficacy of inhaled corticosteroids. Fluticasone propionate is a relatively new inhalational corticosteroid compared to older ones like beclomethasone and budesonide. Aims & Objective: To assess the relative efficacy of fluticasone propionate administered from different delivery devices to adult patients of chronic stable bronchial asthma as measured by pulmonary function test parameters. Material and Methods: This prospective study was undertaken to assess the relative efficacy of fluticasone propionate administered from different delivery devices to adult patients of chronic stable bronchial asthma as measured by pulmonary function test parameters. Fourty eight subjects were administered, fluticasone propionate (250 μg) by dry powder inhaler, metered dose inhaler, metered dose inhaler with spacer and fluticasone (1mg) via nebulizer consecutively each week for four weeks under direct supervision. Pulmonary function test was done before and one hour after administration of the drug on each visit. Results: After excluding nine patients who were lost to follow up, data was analysed for the remaining thirty nine patients and no significant difference in peak expiratory flow rate (p=0.77), forced expiratory volume in one second (p=0.95), forced vital capacity (p=0.24) and forced expiratory volume in one second and forced vital capacity ratio (p=0.22) was seen after giving fluticasone by different devices. Conclusion: Fluticasone propionate delivered by different devices like dry powder inhaler, metered dose inhaler, metered dose inhaler with spacer and nebulizer have similar effect on lung function in patients of chronic stable bronchial asthma and may be used interchangeably.
topic peak expiratory flow rate
forced vital capacity
metered dose inhaler
fluticasone propionate
url https://jcdr.net/articles/PDF/3348/22-%206705_E(%20_%20)_PF1(%20_%20)_F(H)_PF1(P)_PF2(PP).pdf
work_keys_str_mv AT bhanuprakashkolasani influenceofdeliverydevicesonefficacyofinhaledfluticasonepropionateacomparativestudyinstableasthmapatients
AT venumadhavilanke influenceofdeliverydevicesonefficacyofinhaledfluticasonepropionateacomparativestudyinstableasthmapatients
AT sudheerdiyya influenceofdeliverydevicesonefficacyofinhaledfluticasonepropionateacomparativestudyinstableasthmapatients
_version_ 1724624598774841344